Letrozole

来曲唑

Report date: 2026/05/25 20:02:40
NME

Base Information

Drug NameLetrozole
Drug Alias NameLetrozolum曲来唑Letzazole来罗唑Letrozol +[10] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAromatase inhibitorsEstrogen receptors antagonists
TargetsAromataseEstrogen receptors
Therapy Area/IndicationsMetastatic breast cancerSolid tumoursHR-positive breast cancer +[35] 
Global Approved IndicationsBreast Neoplasms
Approved Indications in ChinaBreast Neoplasms
Original Approved Country/TerritorySwedenSwitzerland
Original Approved Date1996/07/01
Country/TerritoryBelgiumCanadaUnited States +[20] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesHunan University Of Traditional Chinese MedicineGog Foundation IncEgymedicalpedia +[22] 
Inactive CompaniesDana-Farber Cancer InstituteUniversity of Texas Southwestern Medical CenterUT Health San Antonio +[24] 
Active IndicationsSolid tumoursHR-positive breast cancerInfertility, Female +[22] 
Inactive IndicationsMetastatic breast cancerPainPuberty, Precocious +[13] 

Other Information

ATC CodeL02BG04
Related LinksWikipediaDrugBankKEGG